Jun 5, 2026 07:35PM
Jun 3, 2026 06:05AM
Jun 3, 2026 06:05AM
May 29, 2026 02:00PM
May 29, 2026 02:00PM
May 29, 2026 12:44PM
May 29, 2026 12:30PM MannKind gets FDA approval for inhaled insulin in children ages 6 and up
May 29, 2026 12:30PM
May 27, 2026 09:06AM
May 27, 2026 09:05AM
May 6, 2026 06:31AM
May 6, 2026 06:30AM
Mar 9, 2026 09:05AM
Mar 9, 2026 09:05AM MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
Feb 26, 2026 08:00AM
Feb 9, 2026 06:10AM
Feb 9, 2026 06:05AM
Jan 27, 2026 08:33AM
Jan 26, 2026 06:05AM
Jan 26, 2026 06:05AM
Jan 23, 2026 12:56PM Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
Jan 8, 2026 08:08AM
Jan 8, 2026 08:05AM
Dec 23, 2025 08:06AM
Dec 23, 2025 08:05AM
Dec 1, 2025 08:05AM
Dec 1, 2025 08:05AM
Nov 5, 2025 08:00AM MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update
Oct 13, 2025 08:05AM
Oct 13, 2025 08:05AM
Sep 3, 2025 06:44AM
Aug 27, 2025 08:06AM
Aug 27, 2025 08:05AM
Aug 25, 2025 07:30AM
Aug 25, 2025 07:30AM MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
Aug 6, 2025 07:05AM
May 8, 2025 08:05AM
Apr 12, 2025 04:00AM
Mar 10, 2025 06:05AM
Feb 26, 2025 04:05PM
Dec 16, 2024 06:06AM
Dec 16, 2024 06:05AM MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)
Nov 7, 2024 04:02PM
Nov 4, 2024 06:05AM
Sep 18, 2024 06:18AM
Sep 18, 2024 06:15AM
Aug 7, 2024 08:00AM
May 29, 2024 08:46AM
May 29, 2024 08:45AM MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With Pulmatrix
May 8, 2024 04:18PM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All